Auto-Injector Market Analysis
The global auto-injector market is predicted to touch USD 125.32 million at a whopping 22.0% CAGR between 2019- 2025, as per the recent report by Market Research Future (MRFR). An auto-injector is a new injectable that has a user-centric design that injects the needle automatically and conducts the surgical process, thus reducing the dependence on healthcare experts. These specialized instruments are used to prevent needle stick injury, thus reducing needle phobia amid patients. Some of the benefits of using auto-injector include improved compliance, improved safety, reduced anxiety, and simplified self-administration.
Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/2046
Various factors are adding to the auto-injector market growth. According to the new MRFR report, such factors include the growing geriatric population, rising availability of generic auto-injectors, technological advances, increasing incidence of lifestyle and chronic diseases, burgeoning demand for patient’s convenience, and innovations in device functions & materials of auto-injectors. Additional factors adding market growth include increasing preference of self-administration of injections by patients, growing awareness about auto-injector devices, and growing prevalence of anaphylactic shock. The different benefits that auto-injectors offer over manual injection, such as more accurate and control in drug delivery, less pain, and more effective are also adding market growth.
On the contrary, the availability of alternatives like constant glucose monitoring devices may limit the auto-injector market growth over the forecast period.
Auto-Injector Market Segmentation
The MRFR report offers an inclusive segmental analysis of the global auto-injector market report based on end user, distribution channel, application, and product type.
By product type, the global auto-injector market is segmented into reusable and disposable. Of these, the disposable auto-injectors will lead the market over the forecast period.
By application, the global auto-injector market is segmented into rheumatoid arthritis, allergies, diabetes, multiple sclerosis, anaphylaxis. Of these, the anaphylaxis segment will dominate the market over the forecast period.
By distribution channel, the global auto-injector market is segmented into rectal, pharmacy, and online retailer.
By end user, the global auto-injector market is segmented into ambulatory surgical centers, hospitals and clinics, and home care settings. Of these, home care settings will have a major share in the market over the forecast period.
Auto-Injector Market Regional Analysis
Based on the region, the global auto-injector market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific (APAC), and Middle East Africa (MEA). Of these, the Americas will dominate the market over the forecast period. Rapid technological advances coupled with rising cases of food allergies & anaphylaxis is adding to the growth of the market in the region. Some common allergies that children experience from food in the US include shellfish, peanut butter, and milk.
The global auto-injector market in Europe is predicted to hold the second-largest share over the forecast period. Rising investments in R&D by private companies, coupled with increasing cases of chronic diseases, are adding to the growth of the market in the region.
The global auto-injector market in the APAC region is predicted to grow at a fast pace over the forecast period. Development and adoption of new product designs, the presence of a huge diabetic patient pool, and a growing population are adding to the growth of the market in the region. Japan, India, and China are the major contributors in the region.
The global auto-injector market in the MEA is predicted to have the smallest share over the forecast period for the poor healthcare infrastructure in the African region.
Auto-Injector Market Key Players
Notable players profiled in the global auto-injector market report include Kaleo, Inc, AstraZeneca, Merck KGaA, Ypsomed AG, Mylan NV, Eli Lilly and Company, Biogen, Teva Pharmaceuticals USA, Amgen Inc., Johnson & Johnson, AbbVie Inc., Dickinson and Company, Owen Mumford Ltd, Becton, Novartis AG, Haselmeier, and Bayer AG.
Table Of Contents:
Chapter 1. Executive Summary
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/auto-injector-market-2046
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar